홈 › 만성 골수성 백혈병 › 텍사스 › Houston
TX Houston의 만성 골수성 백혈병 임상 시험
만성 골수성 백혈병 관련 연구 18개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
피험자 모집 중2상
- M D Anderson Cancer Center, Houston
Asciminib Roll-over Study
피험자 모집 중4상
- Uni Of TX MD Anderson Cancer Cntr, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- UT MD Anderson Cancer Center, Houston
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
피험자 모집 중2상
- MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
피험자 모집 중관찰 연구
- Texas Children's Hospital, Houston
TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
피험자 모집 중1/2상
- The University of Texas M.D. Anderson Cancer Center, Houston
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
피험자 모집 중2상
- The University of Texas M. D. Anderson Cancer Center, Houston
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
피험자 모집 중관찰 연구
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
피험자 모집 중2상
- MD Anderson Cancer Center, Houston
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
피험자 모집 중1상
- M D Anderson Cancer Center, Houston
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
피험자 모집 중2상
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
피험자 모집 중3상
- Ascentage Investigative Site #1501, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
피험자 모집 중관찰 연구
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
피험자 모집 중2상
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
피험자 모집 중1상
- University of Texas MD Anderson Cancer Center, Houston
다른 도시의 만성 골수성 백혈병 시험
- Seattle, WA연구 11개
- New York City, NY연구 10개
- Portland, OR연구 7개
- Baldwin Park, CA연구 7개
- Chicago, IL연구 7개
- Detroit, MI연구 6개
- Birmingham, AL연구 6개
- Philadelphia, PA연구 6개
- St. Louis, MO연구 6개
- Milwaukee, WI연구 5개
- Nashville, TN연구 5개
- Atlanta, GA연구 5개
Houston의 다른 연구
- 비소세포폐암연구 143개
- 유방암연구 126개
- 암 (전체)연구 124개
- 대장직장암연구 101개
- 전이성 암연구 100개
- 난소암연구 90개
- 급성 골수성 백혈병연구 88개
- 폐암연구 78개
- 전립선암연구 73개
- 자궁내막암연구 69개
- 흑색종연구 61개
- 췌장암연구 59개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.